EAPC Premium Access

The relationship of drug treatment safety parameters and adherence to pharmacotherapy in patients with cardiovascular diseases (according to the data of the outpatient registry)

Presentation

About the speaker

Doctor Yulia Lukina

National Medical Research Center for Preventive Medicine, Moscow (Russian Federation)
0 follower

13 more presentations in this session

Prognostic impact of proton pump inhibitors in patients after elective percutaneous coronary intervention with implantation of second-generation drug eluting stents

Speaker: Doctor O. Shahmatova (Moscow, RU)

Thumbnail

A novel direct method to evaluate adherence to atorvastatin therapy in coronary prevention - Cut-off values generated in a clinical non-adherence study

Speaker: Doctor O. Kristiansen (Drammen, NO)

Thumbnail

Focus-group as a qualitative method for study of compliance in cardiovascular disease patients and their doctors

Speaker: Doctor O. Semenova (Saratov, RU)

Thumbnail

Adherence to long-term treatment and some traits of patients and their doctors: a prospective study of treatment compliance in patients with cardiovascular diseases

Speaker: Doctor Y. Bulaeva (Saratov, RU)

Thumbnail

The impact of anaemia and intravenous iron replacement therapy on exercise capacity in patients after cardiac surgery.

Speaker: Doctor C. Nugara (Palermo, IT)

Thumbnail

Access the full session

Poster Session 1 - Cardiovascular Pharmacotherapy

Speakers: Doctor Y. Lukina, Doctor O. Shahmatova, Doctor O. Kristiansen, Doctor O. Semenova, Doctor Y. Bulaeva...
Thumbnail

About the event

Image

EuroPrevent 2019

11 April - 13 April 2019

Sessions Presentations

This platform is supported by

logo Novo Nordisk